Cargando…
Cryopreserved Versus Fresh Peripheral Blood Allogeneic Stem Cell Transplantation during COVID 19 Pandemic: A Single Center Experience
Autores principales: | Guo, Mengni, Liu, Jieying, Clark, Pamela, Ahmed, Zohaib, Jalil, Anum, Varela, Juan Carlos, Patel, Rushang D, Mori, Shahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930041/ http://dx.doi.org/10.1016/S2666-6367(22)00450-X |
Ejemplares similares
-
Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience
por: Guo, Mengni, et al.
Publicado: (2022) -
The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study
por: de Greef, Georgine E., et al.
Publicado: (2018) -
CAR NK-92 cell–mediated depletion of residual TCR(+) cells for ultrapure allogeneic TCR-deleted CAR T-cell products
por: Kath, Jonas, et al.
Publicado: (2023) -
Sars-Cov-2 Infections in CAR T Cell Recipients
por: McNerney, Kevin O., et al.
Publicado: (2021) -
Conquering the Cytokine Storm in COVID-19 Induced ARDS Using Placenta-Derived Decidua Stromal Cells
por: Ringden, Olle, et al.
Publicado: (2022)